Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001104659-25-008356
Filing Date
2025-02-03
Accepted
2025-02-03 07:05:46
Documents
10
Effectiveness Date
2025-02-03

Document Format Files

Seq Description Document Type Size
1 S-3ASR tm254783-1_s3asr.htm S-3ASR 688641
2 EXHIBIT 1.2 tm254783d2_ex1-2.htm EX-1.2 212751
3 EXHIBIT 4.6 tm254783d2_ex4-6.htm EX-4.6 322771
4 EXHIBIT 4.7 tm254783d2_ex4-7.htm EX-4.7 304884
5 EXHIBIT 5.1 tm254783d2_ex5-1.htm EX-5.1 54283
6 EXHIBIT 23.1 tm254783d2_ex23-1.htm EX-23.1 2083
7 EX-FILING FEES tm254783d2_ex-filingfees.htm EX-FILING FEES 67224
8 GRAPHIC tm254783d2_ex5-1img001.jpg GRAPHIC 3421
9 GRAPHIC tm254783d2_ex5-1img002.jpg GRAPHIC 1902
10 GRAPHIC lg_arrivent-4c.jpg GRAPHIC 11980
  Complete submission text file 0001104659-25-008356.txt   1678128
Mailing Address 18 CAMPUS BLVD. SUITE 100 NEWTOWN SQUARE PA 19073-3269
Business Address 18 CAMPUS BLVD. SUITE 100 NEWTOWN SQUARE PA 19073-3269 240-780-6356
ArriVent BioPharma, Inc. (Filer) CIK: 0001868279 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-284661 | Film No.: 25580581
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)